SINGLETO2 Therapeutics LLC

Biotechnology company · Summit, New Jersey, United States

SINGLETO2 Therapeutics LLC is a biotechnology company headquartered in Summit, New Jersey, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2 million in total, most recently in 2024.

www.singleto2.comProfile compiled from public records. Is this your company? Request a correction or update

SINGLETO2 Therapeutics at a glance

Typebiotechnology company

HeadquartersSummit, New Jersey, United States

Employees (self-reported, 2024)4

What does SINGLETO2 Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $2 million in total (2016 to 2024). NIH funding came from the National Institute of Dental and Craniofacial Research, National Institute of Allergy and Infectious Diseases.

Frequently asked questions about SINGLETO2 Therapeutics

Where is SINGLETO2 Therapeutics headquartered?

SINGLETO2 Therapeutics LLC is headquartered in Summit, New Jersey, United States.

What does SINGLETO2 Therapeutics do?

SINGLETO2 Therapeutics LLC is a biotechnology company.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences